COVID-19 Response

Improvements to scheduling and pharmacy care will support co-administration of flu vaccine and new reformulated COVID-19 boosters at more than 1,700 pharmacy locations.

The bivalent vaccines have been authorized for use as a single booster dose at least two months after primary or booster vaccination.

Earlier this month, the FDA authorized state-licensed pharmacists to prescribe Paxlovid to eligible patients aged 12 years old and older, with certain limitations.

Testing is available at no out-of-pocket cost for qualified insured individuals at Rite Aid drive-thru locations with an appointment.

The Hy-Vee subsidiary will offer Evusheld at its 19 locations throughout the U.S.

NACDS and NCPA commended the FDA for authorizing pharmacists to prescribe Paxlovid, but continue to urge the government to take action to ensure pharmacists are reimbursed for their services.

NACDS’ “Pharmacies. The face of neighborhood health care” campaign tells the story of pharmacies’ effectiveness in serving the American public during emergencies and every day.

Hy-Vee is operating pharmacy hubs dedicated to only administering pediatric COVID-19 vaccines during select times.

Rite Aid announced that at select Rite Aid locations, including Rite Aid-owned Bartell Drugs, it will be providing Pfizer-BioNTech COVID-19 vaccines to children ages 3 years old and older once shipments arrive to select pharmacies later this week.

The Biden administration is planning for all scenarios, including for the first vaccinations to start as early as the week of June 20, with the program ramping up over time.

​​​​​​​If emergency use authorization is granted by the FDA, the Novavax COVID-19 vaccine would become the first protein-based COVID-19 vaccine available in the United States.

Sixty-six percent of pharmacists would be prepared to administer COVID-19 vaccines to children under 5 years old if authorized to do so.